Viralytics' new CAVATEK study to be held in the UK

Singapore: The next Viralytics clinical study evaluating multi doses of CAVATAK administered by the intravenous route ...

December 10, 2012 | Monday | News
FDA doesn't approve Pharmaxis' Bronchitol

Singapore: Pharmaxis received a complete response letter from the US FDA confirming that Bronchitol cannot yet be appro...

March 20, 2013 | Wednesday | Regulatory
APAC coronary stent sector to touch $1.5 bn in 2015

Singapore: Asia-Pacific, including Japan, China, India, New Zealand, South Korea and Australia, is the fastest growing r...

April 9, 2015 | Thursday | Analysis
Track the walk: a fall-proof method

Singapore: CDC predicts that every year, one in every three adults in the age group of 65 or older falls and around 2 mi...

November 22, 2014 | Saturday | Analysis
MNCs on medtech growth trail

Industry forecasts by market analysts state that 80 percent of the multinational companies expect to gain a good share i...

November 5, 2013 | Tuesday | Analysis
Biochips market to be worth $11.4 bn by 2018

Singapore: A recent report released by RnRMarketResearch.com has analyzed the Global Biochips Industry and forecasted th...

July 9, 2013 | Tuesday | News
Physicians, consumers lack trust in Aus healthcare

Singapore: Australia boasts an advanced healthcare system supported by both the public and private sector involvement. T...

February 13, 2013 | Wednesday | Analysis
EMA gives Patrys cancer drug orphan status

Singapore: Australia-based Patrys, a clinical stage biotechnology company, has been granted orphan drug designation by t...

September 12, 2013 | Thursday | News
Novogen drug candidate effective as anti-cancer agent in preclinical studies

Singapore: US-Australian drug discovery company, Novogen's drug candidate, Anisina, has progressed successfully in pre-c...

May 14, 2015 | Thursday | News
Australian biotech firm makes stem cell breakthrough

Singapore: Australia-based Cynata Therapeutics has made a breakthrough by devising a technique to mass manufacture stem ...

February 19, 2015 | Thursday | News
Translation of ideas is Australia's key to growth'

Over the past decade the world's centre of economic gravity has shifted from US and Europe to Asia at a speed and scale ...

September 30, 2014 | Tuesday | Analysis
CSL to expand its Melbourne plant

Singapore: CSL announced that it has clinched a deal with the Victorian government to expand its Melbourne plasma manufa...

October 9, 2014 | Thursday | News
TGA approves Telezon's SoloFlow

Singapore: Telezon's flagship SoloFlow Reconstitution Needle (polymer needle) has been accepted by Therapeutic Goods Aus...

October 18, 2013 | Friday | News
Allied commences Cardiocel sale in Europe

Singapore: Australia based Allied Healthcare has started commercializing CardioCel into Europe after the Company receive...

November 8, 2013 | Friday | News
China and Australia grant patent to NBB nicotine biosynthesis gene

Singapore: 22nd Century Group, a company that has developed pioneering technology for tobacco harm reduction and smoking...

July 10, 2012 | Tuesday | Regulatory
Australia grants $7 mn to uplift cancer research

Singapore: Cancer Council NSW, Australia's non-government cancer research funder, has granted almost $7 million to resea...

May 11, 2015 | Monday | News
Novogen progresses on drug for paediatric brain cancer

Singapore: US-Australian drug discovery company, Novogen, in conjunction with Australian paediatric cancer researchers, ...

May 8, 2015 | Friday | News
Novogen develops drug to enhance chemotherapy effect

Singapore: Australian drug discovery company, Novogen, has developed anti-tropomyosin drug candidate, Anisina, which has...

July 15, 2015 | Wednesday | News